Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linezolid-associated peripheral neuropathy.

Jennifer P Rho1, Irene G Sia, Brian A Crum

  • 1Division of General Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|July 13, 2004
PubMed
Summary

Linezolid, an important antibiotic, can cause peripheral neuropathy, a nerve-damaging side effect. This risk increases with prolonged use beyond the recommended duration, requiring medical attention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inviting Participants to the Table: Application of the Data Placemats for Disseminating Research Results.

Progress in community health partnerships : research, education, and action·2026
Same author

Hepatocellular Carcinoma in Southeast Asian Americans: Epidemiologic Trends, Screening Challenges, and Policy Implications.

Healthcare (Basel, Switzerland)·2026
Same author

"We are all Human Beings That Deserve the Same Opportunities as Everyone Else": Immigrant Perspectives on Health in Southeast Minnesota: A Photovoice Study.

Health promotion practice·2026
Same author

Mayo Clinic Framework for Community-Engaged Research: Development, Implementation, and Impact.

Mayo Clinic proceedings·2026
Same author

Lyme in the prosthetic joint: two cases and a review of the literature.

Journal of bone and joint infection·2026
Same author

Keeping the FAITH!: Psychosocial Factors and Healthy Lifestyle Among African-Americans During the COVID-19 Pandemic.

Health promotion practice·2025

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Neurology

Background:

  • Linezolid is a novel oxazolidinone antibiotic approved for resistant gram-positive infections.
  • It is effective against challenging pathogens like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Observation:

  • Two patients developed peripheral neuropathy during or after extended linezolid therapy.
  • Peripheral neuropathy is a potentially serious adverse effect of linezolid treatment.

Findings:

  • Linezolid-associated peripheral neuropathy is not widely documented.
  • Cases of neuropathy are more common in patients treated for longer than the recommended 28 days.

Implications:

Related Experiment Videos

  • Healthcare providers should monitor patients for signs of peripheral neuropathy.
  • Awareness of this adverse effect is crucial for safe and effective linezolid use.
  • Further research may be needed to elucidate the mechanisms and risk factors for linezolid-induced neuropathy.